These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 628780)

  • 21. Proton induced reactions on natural Pb targets. A potential new cyclotron method for 201 Tl production.
    Lagunas-Solar MC; Little FE; Jungerman JA
    Int J Appl Radiat Isot; 1981 Nov; 32(11):817-22. PubMed ID: 6273326
    [No Abstract]   [Full Text] [Related]  

  • 22. Cyclotron targetry for production of short-lived positron emitters.
    Schlyer DJ
    Acta Radiol Suppl; 1991; 376():11-4. PubMed ID: 1666737
    [No Abstract]   [Full Text] [Related]  

  • 23. Therapeutic radionuclides: production and decay property considerations.
    Volkert WA; Goeckeler WF; Ehrhardt GJ; Ketring AR
    J Nucl Med; 1991 Jan; 32(1):174-85. PubMed ID: 1988628
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Accelerator production of tritium as a future source of medical radionuclides.
    Spicer KM; Baron S; Frey GD
    J Nucl Med; 1998 Apr; 39(4):20N, 28N. PubMed ID: 9544655
    [No Abstract]   [Full Text] [Related]  

  • 25. [Current topics in radiopharmaceuticals in Japan. (III) Cyclotron-radiopharmaceuticals and clinical applications].
    Ido T
    Radioisotopes; 1984 Feb; 33(2):109-14. PubMed ID: 6610890
    [No Abstract]   [Full Text] [Related]  

  • 26. The Argonne National Laboratory 60 inch cyclotron.
    Friedman A
    Prog Nucl Med; 1978; 4():132-9. PubMed ID: 628771
    [No Abstract]   [Full Text] [Related]  

  • 27. Production of 66Ga and 67Ga at a compact cyclotron.
    Szelecsényi F; Tárkányi F; Kovács Z; Bergman J; Heselius SJ; Solin O
    Acta Radiol Suppl; 1991; 376():62-3. PubMed ID: 1666783
    [No Abstract]   [Full Text] [Related]  

  • 28. New isotope production company gearing up for nuclear medicine industry.
    Kotz D
    J Nucl Med; 1998 Apr; 39(4):17N-18N, 27N. PubMed ID: 9544653
    [No Abstract]   [Full Text] [Related]  

  • 29. [Practical issues in revision of radiation hazards prevention regulations of hospitals regarding radioactivation of medical accelerators; accompanying the revision of law concerning prevention from radiation hazards due to radioisotopes, etc., which come into force on April 1, 2012 in Japan].
    Nihon Hoshasen Gijutsu Gakkai Zasshi; 2012; 68(8):1071-5. PubMed ID: 23133878
    [No Abstract]   [Full Text] [Related]  

  • 30. The medical case for an Australian national cyclotron facility.
    Morris JG; Boyd RE; Smith RS; Hardy CJ; Towson JE; Bautovich GJ; Hutton BF
    Med J Aust; 1985 Apr; 142(8):454-7. PubMed ID: 3872404
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Plans for radiopharmaceutical production at TRIUMF.
    Pate BD
    Prog Nucl Med; 1978; 4():61-2. PubMed ID: 628785
    [No Abstract]   [Full Text] [Related]  

  • 32. Model analysis of transcapillary exchange: the role of cyclotron produced isotopes in the study of the capillary permeability of substances.
    Keinänen MT; Kuikka JT
    Med Biol; 1980 Jun; 58(3):128-39. PubMed ID: 7019593
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cross section measurements of the (131)Xe(p,n) reaction for production of the therapeutic radionuclide (131)Cs.
    Tárkányi F; Hermanne A; Takács S; Rebeles RA; Van den Winkel P; Király B; Ditrói F; Ignatyuk AV
    Appl Radiat Isot; 2009 Oct; 67(10):1751-7. PubMed ID: 19520583
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The LASL medical radioisotope research program: an overview of LAMPF and the isotope production facility.
    O'Brien HA; Ogard AE; Grant PM
    Prog Nucl Med; 1978; 4():16-22. PubMed ID: 628774
    [No Abstract]   [Full Text] [Related]  

  • 35. Commercial isotope venture from defunct SSC.
    Miller L
    J Nucl Med; 1994 Oct; 35(10):19N, 23N-24N. PubMed ID: 7931678
    [No Abstract]   [Full Text] [Related]  

  • 36. The Energy Department's modest proposal.
    Rojas-Burke J
    J Nucl Med; 1993 Apr; 34(4):13N-14N, 17N-18N. PubMed ID: 8455069
    [No Abstract]   [Full Text] [Related]  

  • 37. Anhydrous F-18 labeled eslemental flurine for radiopharmaceutical preparation.
    Casella V; Ido T; Wolf AP; Fowler JS; MacGregor RR; Ruth TJ
    J Nucl Med; 1980 Aug; 21(8):750-7. PubMed ID: 7400831
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Technology for the production of 199Tl by the 197Au(alpha, 2n) reaction].
    Rösch F; Novgorodov AF; Herrmann R; Kolaczowski A; Mikecz P; Zielinski A
    Radiobiol Radiother (Berl); 1987; 28(6):827-30. PubMed ID: 3444884
    [No Abstract]   [Full Text] [Related]  

  • 39. Relative biological effectiveness (RBE) of p(26) + Be neutrons from the King Faisal Specialist Hospital and Research Centre CS-30 cyclotron measured by testis weight loss.
    Feola JM; Aissi A; Greer W; el-Sayed R; Clubb B; el-Akkad S
    Strahlenther Onkol; 1989 Nov; 165(11):817-23. PubMed ID: 2688155
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Guidelines for evaluation of safety standards associated with hospital cyclotron-produced radiopharmaceuticals. Subcommittee on Medical Application of Cyclotron-produced Radionuclides, Medical and Pharmaceutical Committee, Japan Radioisotope Association].
    Radioisotopes; 1986 Nov; 35(11):616-8. PubMed ID: 3809614
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.